Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Citizen Petitions Cannot Be Used To Block Generics - FDA Proposed Rule

Executive Summary

Innovator pharmaceutical companies will not be able to block approval of generic drugs by using the citizen petition mechanism, according to FDA's Nov. 30 proposed rule to revise the petition process.

You may also be interested in...



Citizen Petition Proposed Rule Withdrawn; FDA Cites Improved Response Rate

FDA is withdrawing its proposed rule to limit citizen petitions due to improvements in its response rate

Citizen Petition Proposed Rule Withdrawn; FDA Cites Improved Response Rate

FDA is withdrawing its proposed rule to limit citizen petitions due to improvements in its response rate

FDA Citizen Petition Rule On Hold; Pregnancy Label Work Continues

FDA is no longer pursuing a final rule on limiting the use of citizen petitions

Related Content

UsernamePublicRestriction

Register

ID1132542

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel